Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN-101 Dose-Finding Study in Moderate to Severe COPD (GOLDEN 6)
NCT02038829Phase 2Completed
- Sponsor
- Sunovion
- Start
- Jan 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glycopyrrolate in chronic obstructive pulmonary disease (COPD) (6 arms), sponsored by Sunovion. Primary endpoint: Change From Baseline in Trough FEV1 at Treatment Visit Day 7 Compared to Placebo. Started Jan 2014; status: completed.
02
Drugs
glycopyrrolate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02038829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038829.